K902991 is an FDA 510(k) clearance for the ICON STREP B IMMUNOENZYMETRIC ASSAY. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.
Submitted by Hybritech, Inc. (San Diego, US). The FDA issued a Cleared decision on October 3, 1990 after a review of 86 days - a notably fast clearance cycle.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Hybritech, Inc. devices